請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/6186完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 楊宏志 | |
| dc.contributor.author | Chun-Chiao Juang | en |
| dc.contributor.author | 莊淳喬 | zh_TW |
| dc.date.accessioned | 2021-05-16T16:22:41Z | - |
| dc.date.available | 2017-09-24 | |
| dc.date.available | 2021-05-16T16:22:41Z | - |
| dc.date.copyright | 2013-09-24 | |
| dc.date.issued | 2013 | |
| dc.date.submitted | 2013-07-22 | |
| dc.identifier.citation | 1. MacCallum, F. O. 1947. Homologous serum jaundice. Lancet. 2: 691-692.
2. World Health Organization. 1973. 3. Blumberg, B. S. 1977. Australia antigen and the biology of Hepatitis B. Science. 4. Blumberg, B. S., B. J. Gerstley, D. A. Hungerford, W. T. London, and A. I. Sutnick. 1967. A serum antigen (Australia antigen) in Down's syndrome, leukemia,and hepatitis. Annals of internal medicine. 66: 924-931. 5. Prince, A.M. 1968. An antigen detected in the blood during the incubation period of serum hepatitis. Proc. Natl Acad Sci USA. 60: 814-821. 6. Dane, D. S., C. H. Cameron, and M. Briggs. 1970. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet. 1: 695-698. 7. Jilbert, A.R., and I. Kotlarski. 2000. Immune responses to duck hepatitis B virus infection Developmental and Comparative. Immunology. 24: 285-302. 8. Schaefer, S. 2006. Hepatitis B virus taxonomy and hepatitis B virus genotypes. World Journal of Gastroenterology. 13: 13-21. 9. Kurbanov,F., Y. Tanaka, and M. Mizokami. 2010. Geographical and genetic diversity of the human hepatitis B virus. Hepatology Research. 40: 14-30. 10. Liaw, Y.F., C.M. Chu. 2009. Hepatitis B virus infection. Lancet. 373: 582-592. 11. Chang, M.H. 2007.Hepatitis B virus infection. Fetal and Neonatal Medicine. 12:160-167. 12. Woo G., G. Tomlinson, Y. Nishikawa, M. Kowgier, M. Sherman, D. K. H. Wong, B. Pham, W. J. Ungar, T. R. Einarson, E. J. Heathcote, and M. Krahn. 2010. Tenofovir and Entecavir are the most effective antiviral agents for chronic hepatitis B: A systematic review and bayesian meta-analyses. Gastroenterology.139:1218–1229. 13. Dienstag J.L. 2008. Hepatitis B Virus Infection. N. ENGL. J. MED. 359:1486-1500. 14. Kaplan P.M., R.L. Greenman, J.L. Gerin, R.H. Purcell, and W.S. Robinson.1973. DNA Polymerase associated with human hepatitis B antigen. J. Virol. 12:995-1005. 15. Bottcher B., S.A, Wynne, and R.A. Crowther. 1997. Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature. 386: 88-91. 16. Crowther F.A., N.A. Kiselev, B. Bottcher, J.A. Berriman, G.P. Borisova, S.V. Ose, and P. Pumpens. 1994. Three-dimensional structure of hepatitis b virus core particles determined by electron cryomicroscopy. Cell. 77: 943-950. 17. Glebe D., and C.M. Bremer. 2013. The molecular virology of hepatitis B virus. seminars in liver disease. 33: 103-112. 18. Kann M., A. Schmitz, and B. Rabe. 2007. Intracellular transport of hepatitis B virus. World J. Gastroenterol. 13: 39–47. 19. Bartenschlager R., M. Junker-Niepmann, and H. Schaller. 1990. The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J. Virol. 64: 5324–5332. 20. Knaus T., and M. Nassal. 1993. The encapsidation signal on the hepatitis B virus RNA pregenome forms a stem-loop structure that is critical for its function. Nucleic Acids Res. 21: 3967–3975. 21. Zhang Y.Y., B.H. Zhang, D. Theele, S. Litwin, E. Toll, and J. Summers. 2003. Single-cell analysis of covalently closed circular DNA copy numbers in a hepa- dnavirus-infected liver. Proc. Natl. Acad. Sci. U.S.A. 100: 12372–12377. 22. Bruss V. 2007. Hepatitis B virus morphogenesis. World J. Gastroenterol. 13: 65–73. 23. Lambert C., T.D oring, and R. Prange. 2007. Hepatitis B virus maturation is sen-sitive to functional inhibition of ESCRT-III, Vps4, and ﰄ2-adaptin. J. Virol. 81:9050–9060. 24. Nassal M. 2008. Hepatitis B viruses: Reverse transcription a different way. Virus Research. 134: 235-249. 25. Lanford R.E., L. Notvall, H. Lee, and B. Beames. 1997. Transcomplementation of nucleotide priming and reverse transcription between independently expressed TP and RT domains of the hepatitis B virus reverse transcriptase. J. Virol. 71: 2996– 3004. 26. Kathleen M. H., and D. D. Loeb. 2007. The sequence of the RNA primer and the DNA template influence the initiation of plus-strand DNA synthesis in hepatitis B virus. J. Mol. Biol. 370: 471–480. 27. Cai D., C. Mills, W. Yu, R. Yan, C.E. Aldrich, J.R. Xu, J.T. Guo, T. M. Block, A. Cuconati, and Guo H. 2012. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA Formation. Antimicrobial Agents and Chemo- therapy. 56: 4277-4288. 28. Guo H., D. Jiang, T. Zhou, A. Cuconati, and T.M. Block. 2007. Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation. J Virol. 81:12472–12484. 29. Sohn J.A., S. Litwin, and C. Seeger. 2009 Mechanism for CCC DNA synthesis in hepadnaviruses. PLoS ONE. 4. 30. Kock J., C. Rosler, J.J. Zhang, H. E. Blum, M. Nassal, and C. Thoma. 2010.Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner. PLoS Pathogens. 6. 31. Wang Y, Y. Li, C. Yang, L. Hui, Q. Han, L. Ma, Q. Wang, G. Yang, and Z. Liuc. 2013. Development and application of a universal Taqman real-time PCR for quantitation of duck hepatitis B virus DNA. 191: 41-47 32. Funk A., M. Mhamdi, H. Will, and H. Sirma. 2007. Avian hepatitis B viruses: Molecular and cellular biology, phylogenesis, and host tropism. World J Gastroenterol. 13: 91-103. 33. Hirsch R.C., D.D. Loeb, J.R. Pollack, and D. Ganem. 1991. Cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA. J. Virol. 65: 3309-3316. 34. Ostrow K.M., and D.D. Loeb. 2004. Chimeras of duck and heron hepatitis B viruses provide evidence for functional interactions between viral components of pregenomic RNA encapsidation. J. Virol. 78: 8780-8787. 35. Ostrow K.M., and D.D. Loeb. 2002. Characterization of the cis-acting contributions to avian hepadnavirus RNA encapsidation. J. Virol. 76: 9087-9095. 36. Tavis J.T., S. Perri, and D. Ganem. 1994. Hepadnavirus reverse transcription initiates within the stem-loop of the RNA packaging signal and employs a novel strand transfer. J. Virol. 68: 3536–3543. 37. Wang, G.-H., and C. Seeger. 1993. Novel mechanism for reverse transcription in hepatitis B viruses. J. Virol. 67: 6507–6512. 38. Maguire M.L., and D.D. Loeb. 2010. Cis-acting sequences that contribute to synthesis of minus-strand DNA are not conserved between hepadnaviruses. J. Virol. 84: 12824–12831. 39. Lien J.M., C.E. Aldrich, and W.S. Mason. 1986. Evidence that a capped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis. J. Virol. 57: 229–236. 40. Loeb D.D., K.J. Gulya, and R. Tian. 1997. Sequence identity of the terminal redundancies on the minus-strand DNA template is necessary but not sufficient for the template switch during hepadnavirus plus-strand DNA synthesis. J. Virol. 71:152–160. 41. Havert M.B., and D. D. Loeb. 1997. Cis-acting sequences in addition to donor and acceptor sites are required for template switching during synthesis of plus-strand DNA for duck hepatitis B virus. J. Virol. 71: 5336–5344. 42. Havert M.B., L. Ji, and D. D. Loeb. 2002. Analysis of duck hepatitis B virus reverse transcription indicates a common mechanism for the two template switches during plus-strand DNA synthesis. J. Virol. 76: 2763–2769. 43. Liu N., R. Tian, and D.D. Loeb. 2003. Base pairing among three cis-acting sequences contributes to template switching during hepadnavirus reverse transcription. PNAS. 100: 1984-1989. 44. Mueller-Hill K., and D.D. Loeb. 2002. Cis-acting sequences 5E, M, and 3E interact to contribute to primer translocation and circularization during reverse transcription of avian hepadnavirus DNA. J. Virol. 76: 4260–4266. 45. Horwich A.L., K. Furtak, J. Pugh, and J. Summers. 1990. Synthesis of hepadnavirus particles that contain replication- defective duck hepatitis B virus genomes in cultured huh7 cells. J. Virol. 64: 642–650. 46. Condreay L.D., C.E. Aldrich, L. Coates, W.S. Mason, T.T. Wu. 1990. Efficient duck hepatitis B virus production by an avian liver tumor cell line. J. Virol. 64:3249-3258. 47. Guo J.T., M. Pryce, X. Wang, M.I. Barrasa, J. Hu, and C. Seeger. 2003. Conditional replication of duck hepatitis B virus in hepatoma cells. J. Virol. 77:1885-1893. 48. Shyu Y.J., H. Liu, X. Deng, and C.D. Hu. 2006. Identification of new fluorescent protein fragments for bimolecular fluorescence complementation analysis under physiological conditions. BioTechniques. 40:61-66. 49. Wang Z., L. Wu, X. Cheng, S. Liu, B. L, H. Li, F.Kang, J. Wang, H. Xia, C. Ping, M. Nassal, and D. Sun. 2013. Replication-competent infectious hepatitis B virus vectors carrying substantially sized transgenes by redesigned viral polymerase translation. BioTechniques. 8. 50. Deng Q., M. Mancini-Bourgine, X. Zhang, M. C. Cumont, R. Zhu, Y.C. Lone, and M.L. Michel. 2009. Hepatitis B virus as a gene delivery vector activating foreign antigenic T cell response that abrogates viral expression in mouse models. Hepatology. 64: 642–650. 51. Zhou T., H. Guo, J.T. Guo , A. Cuconati, A. Mehta , and T. M. Block. 2006. Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays. Antiviral Research. 72: 116–124. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/6186 | - |
| dc.description.abstract | Hepadnavirus, including hepatitis B virus (HBV), possesses a partial double-strand DNA genome, also known as relaxed circular DNA (RC-DNA), which is converted to covalently closed circular DNA (cccDNA), a critical template for hepadnavirus replication, after entry to the hepatocytes. However, little is known about the detailed mechanisms regulating the conversion from RC-DNA to cccDNA. Detection of cccDNA usually requires Southern blotting, which is quite labor-intensive. Therefore, a convenient in vitro cccDNA reporter system should facilitate the research of cccDNA. However, in the present there is still no in vivo and in vitro system that can support efficient HBV infection and cccDNA formation. In contrast, duck hepatitis B virus (DHBV) can efficiently form cccDNA in human cell lines as long as its pregenomic DNA is made. In this study, we utilized DHBV system to construct the cccDNA reporter for ready detection of cccDNA formation. We first showed that trans-complementation of core and polymerase could rescue the replication cycle of core- and polymerase-deficient DHBV mutants. We then generated an array of deletion mutations that spanning the region between the start codons of core and polymerase genes. Interestingly, we found that the region between the poly A signal and the start codon of polymerase gene could be deleted without significant reduction of cccDNA formation. Thus, we inserted two reporter genes, the zeocin-resistant gene and a fluorescent protein into this region. Using Southern blotting, we demonstrated that they both maintain the ability to produce cccDNA and RC-DNA, indicating the feasibility of our reporter system. Further experiments are required to prove its utility in serving as a reporter of hepadnavirus cccDNA. | en |
| dc.description.provenance | Made available in DSpace on 2021-05-16T16:22:41Z (GMT). No. of bitstreams: 1 ntu-102-R00445105-1.pdf: 2208561 bytes, checksum: 9fb4b1d9f8af5a8ff498ff3ad83ed483 (MD5) Previous issue date: 2013 | en |
| dc.description.tableofcontents | 中文摘要 ........................................ 5
ABSTRACT .................................... 6 TABLE of CONTENTS .................. 8 LIST of FIGURES ........................ 10 1. INTRODUCTION ................... 11 1.1 The history of hepatitis B virus .................... 11 1.2 The classification of hepatitis B virus ............................... 11 1.3 Epidemiology and the natural history of HBV infection .................... 12 1.4 The current challenges in treatment of chronic HBV infection ...... 14 1.5 Virion structure and genome organization ..................... 15 1.6 The replication cycle of human HBV .................................. 16 1.6.1 HBV replication cycle ....................... 16 1.6.2 From pgRNA to RC-DNA (Reverse transcription) .............. 17 1.6.3 From RC-DNA to cccDNA ................ 18 1.7 DHBV, a good model for studying cccDNA formation of hepadnaviruses .......... 19 1.8 DHBV cis-acting sequences that contribute to the replication cycle .................... 19 1.8.1 DHBV cis-acting sequences involved in encapsidation ........................... 19 1.8.2 DHBV cis-acting sequence that contribute to negative-strand DNA synthesis. .. 20 1.8.3 DHBV cis-acting sequence that contribute to RC-DNA positive-strand synthesis and cccDNA formation............................... 21 1.9 The effect of the size of the inserted DNA on DHBV replication ..... 21 2. SPECIFIC AIM ........................ 23 3. MATERIAL AND METHODS ...................... 24 3.1 Plasmids ........................................ 24 3.2 Cell lines and cell culture system ................. 25 3.3 DNA transfection ......................... 26 3.4 Modified Hirts’ extraction method .............. 27 3.5 Southern blot analysis ..................................... 28 3.6 DIG-labeled DNA probe synthesis ................ 29 4. RESULTS .................................. 31 4.1 The strategies to construct a DHBV cccDNA reporter ........................ 31 4.2 Production of RC-DNA and cccDNA from the DHBV expression plasmids .......... 32 4.3 Complementation of the core- and polymerase-deficient DHBV by the core- and polymerase-expressing vectors .................. 33 4.4 Construct of a series of core-deletion DHBV mutants ........................ 35 4.5 Construct of the cccDNA reporters D1SVC155 and D1SZeocin ........ 36 4.6 Construct of the DHBV1S dimer for analysis the activity of the DHBV promoter in Huh7 cells ....................................... 38 5. DISCUSSION ........................... 40 6.REFERENCE ............................ 44 7. FIGURE ................................... 49 LIST of FIGURES Figure 1. The life cycle of HBV. .............. 49 Figure 2. Establishment of a cccDNA reporter system……………………50 Figure 3. Formation of RC-DNA and cccDNA in 293T and Huh7 cells transfected with DHBV and DHBV1S plasmids. ............................. 51 Figure 4. Complementation of core-deficient and polymerase-deficient DHBV mutants. ............................. 52 Figure 5. Complementation of series of core-deletion DHBV mutants. .................. 54 Figure 6. Bimolecular fluorescence complementation of Venus fluorescence genes. .................... 56 Figure 7. Complementation of D1SVC155. .................. 57 Figure 8. Complementation of D1SZeocin. .................. 58 Figure 9. Formation of RC-DNA and cccDNA in Huh7 cells transfected with DHBV1S dimer plasmid. ......................... 59 | |
| dc.language.iso | en | |
| dc.title | 建立肝臟去氧核醣核酸病毒中共價閉合環狀去氧核醣 核酸的報告基因系統 | zh_TW |
| dc.title | Construction of a Reporter System for the formation of hepadnavirus covalently closed circular DNA | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 101-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 施嘉和,葉秀慧,董馨蓮 | |
| dc.subject.keyword | B 型肝炎病毒,鴨子B 型肝炎病毒,共價閉合環狀去氧核醣核酸,偵測基因,南方墨點法, | zh_TW |
| dc.subject.keyword | Hepatitis B virus (HBV),Duck hepatits B virus (DHBV),cccDNA,reporter genes,Southern blot,complementation, | en |
| dc.relation.page | 59 | |
| dc.rights.note | 同意授權(全球公開) | |
| dc.date.accepted | 2013-07-22 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 微生物學研究所 | zh_TW |
| 顯示於系所單位: | 微生物學科所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-102-1.pdf | 2.16 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
